Use App
Trending
News
Earnings
All
DIA
0.08%
SPY
0.07%
QQQ
1.35%
Trending
META
8.67%
MU
11.55%
JACK
10.12%
CEG
4.76%
DRAM
13.15%
TDOC
7.31%
RIOT
12.34%
KORU
27.43%
ONDO
4.92%
SOUN
4.33%
META
8.67%
MU
11.55%
JACK
10.12%
CEG
4.76%
DRAM
13.15%
TDOC
7.31%
RIOT
12.34%
KORU
27.43%
ONDO
4.92%
SOUN
4.33%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
VTGN
Exchange:
NASDAQ
·
Updated 07:58 PM EDT
VTGN
VistaGen Therapeutics Inc
$0.243
$0.017
(7.52%)
Today
·
Closed $0.243
$0.0006
(0.25%)
After Hours
1
8
,
1
6
9
News
·
This Stock Lost 71% Of Value After Anxiety Therapy Missed Key Goals – But Retail Believes It’s Oversold, Says Won’t Panic-Sell
1
8
,
1
6
9
Reported Earnings
Jun 15
Mkt Cap
$9.27M
Vol
14.58M
Full Chart
Fundamentals
Mkt Cap
$9.27M
Volume
-
52W High
$5.14
52W Low
$0.198
PE Ratio
-0.13
Avg. Volume
3.21M
EPS (Annual)
-$1.83
P/B
0.27
Rev/Employee
$30,951.22
Earnings
Jun 15
Advertisement
|
Remove ads.
Latest VTGN News
View
This Stock Lost 71% Of Value After Anxiety Therapy Missed Key Goals – But Retail Believes It’s Oversold, Says Won’t Panic-Sell
Stocktwits
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Business Wire
Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
Business Wire
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile